how many people are taking glp 1 GLP-1 Survey: 37.5% of Stop GLP-1s after Just 3 Months In recent years, GLP-1 medications

Grossman, MD, has over 40 years of experience in anti-aging and regenerative medicine

The KKR-backed, Switzerland-headquartered group synthesizes peptides from discovery through commercial supply, adding GMP manufacturing for clinical and commercial programs

Recent studies have shown that GLP-1 drugs like Ozempic may: Reduce neuroinflammation Chronic inflammation in the brain is a key driver of Alzheimers progression

Based on product descriptions and similar formulations, the capsules probably include stimulants for energy and focus, appetite suppressants, ingredients targeting inflammation, and compounds with some evidence for influencing incretin hormones